Sign in
4

Changes in Ownership

ANI PHARMACEUTICALS INC Filed Acc 0001871002-24-000010

SVP - CORP. DEV. & STRATEGY sold 20,000 shares at $66.62 ($1,332,400)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Gassert Chad · SVP - CORP. DEV. & STRATEGY

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-05-01 Sale : show line 1 in the form 10b5-1 −20,000 $66.62 $1,332,400 233,226 I
Open-market sales · 20,000 sh · avg $66.62 · $1,332,400
Loading xslF345X05/wk-form4_1714772885.xml…